Discovery of a master cardiac stem cell that appears to give rise to all the major parts of the heart, stem cell treatments for coronary disease will establish another major step in the medical science.
Scientists have discovered what they believe could be cardiac master cells, capable of developing into different tissues in the heart. Groups of US scientists, working independently, have discovered two separate candidates.
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) reported today that a study published in the advanced online edition of the journal Nature supported and elaborated TB4’s significant effects in the damaged hearts of mice and highlighted its therapeutic potential for the treatment of heart attacks and heart failure in humans.
Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.
Cells in the outermost layer of the heart can be guided by a specific protein to move deeper inside and help to repair a failing adult heart. Research published today by Nature, reveals how thymosin ?4, a protein already known for its ability to reduce muscle cell loss after heart attack, can instruct the heart to heal itself.
It is being reported in the Journal Nature, that stem cell injections given to dogs may hold clues to treating people with muscular dystrophy.
Vaccinating mice with embryonic stem cells appears to have prevented lung cancer in the mice, a team of researchers say.
Early mortality rates for ST-segment elevation myocardial infarction in randomized trials have decreased dramatically over the past 20 years, from 13-percent one-month mortality in 1986 to less than 4 percent today.
Four research studies presented at Scientific Sessions point to new directions that offer the first promising results in several years.
Fiona See, Ph.D., postdoctoral research fellow in the laboratory of Dr. Silviu Itescu, M.B., B.S., will present two groundbreaking abstracts on repairing damage from heart failure with stem cells at AHA this year.